VerAvanti

Bothell, United States

VerAvanti seeks to become the world's foremost provider of cutting-edge, single use intravascular endoscopic technologies.

$5.0M raised

Oct 2025

Series A

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about VerAvanti

How much funding has VerAvanti raised?

VerAvanti has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Where is VerAvanti headquartered?

VerAvanti is headquartered in Bothell, United States.

What does VerAvanti do?

VerAvanti seeks to become the world's foremost provider of cutting-edge, single use intravascular endoscopic technologies.

What stage is VerAvanti at?

VerAvanti is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 20, 2025.

MLA

"VerAvanti — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/veravanti. Accessed June 16, 2026.

APA

VCBacked. (2025). VerAvanti — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/veravanti

Wikipedia (cite web)

{{cite web |title=VerAvanti — Funding & Investors |url=https://www.vcbacked.co/company/veravanti |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 20, 2025.